LicianPro

Kalpate Patel

Equity research analyst · Wolfe Research

Earnings calls

1

Nov 2, 2026 – Nov 2, 2026

Stocks asked about

1

Questions

1

Firm rating actions

0

on these stocks, from news

Coverage

Companies whose earnings calls Kalpate Patel asked questions on (from Lician's transcripts).

Questions on earnings calls

    • 49:12
      “For Ocular Deb, for those two patients that withdrew, would those be counted in the ITT efficacy population and any color on how you might handle in complete crossover data in the primary analysis, that would be useful. And then for the NK program, you mentioned that you're…”

Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.

Wolfe Research rating actions on these stocks

From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Kalpate Patel. We do not use licensed rating databases.

No rating action by Wolfe Research on these stocks in the headlines we store yet.